The Cooper Companies, Inc.  

(Public, NYSE:COO)   Watch this stock  
Find more results for Daniel R. Cooper
+2.49 (1.64%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 152.08 - 154.98
52 week 116.95 - 154.98
Open 152.19
Vol / Avg. 562,357.00/568,517.00
Mkt cap 7.41B
P/E 25.63
Div/yield 0.03/0.04
EPS 6.03
Shares 47.94M
Beta 0.34
Inst. own 100%
Sep 1, 2014
Q3 2014 The Cooper Companies, Inc. Earnings Release (Estimated) Add to calendar
Jun 30, 2014
The Cooper Companies Announces Definitive Agreements to Acquire Sauflon Pharmaceuticals Ltd - Webcast
Jun 17, 2014
Cooper Companies Inc at Wells Fargo Healthcare Conference
Jun 12, 2014
The Cooper Companies, Inc. at William Blair & Company LLC Growth Stock Conference
Jun 5, 2014
Q2 2014 The Cooper Companies, Inc. Earnings Conference Call - Webcast
Jun 5, 2014
Q2 2014 The Cooper Companies, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '14) 2013
Net profit margin 19.31% 18.70%
Operating margin 21.57% 19.27%
EBITD margin - 28.49%
Return on average assets 10.08% 9.77%
Return on average equity 12.75% 12.88%
Employees 8,000 -
CDP Score - -


Suite 590, 6140 Stoneridge Mall Road
United States - Map
+1-925-4603600 (Phone)
+1-925-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness with a collection of spherical, toric and multifocal contact lenses. CooperSurgical offers an array of products used in the care and treatment of women's health. The Company participates in the women's healthcare market through offering quality products, technologies and service to clinicians worldwide.

Officers and directors

A. Thomas Bender Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Weiss President, Chief Executive Officer, Non-Independent Director
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allan E. Rubenstein M.D. Independent Vice Chairman of the Board, Lead Director
Age: 65
Bio & Compensation  - Reuters
Gregory W. Matz Chief Financial Officer, Chief Risk Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Paul L. Remmell President and Chief Executive Officer of CooperSurgical Inc.
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel G. McBride Esq. Chief Operating Officer, Executive Vice President; President of CooperVision, Inc.
Age: 49
Bio & Compensation  - Reuters
Carol R. Kaufman Executive Vice President, Chief Administrative Officer, Secretary, Chief Governance Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tina Maloney Principal Accounting Officer, Corporate Controller
Age: 51
Bio & Compensation  - Reuters
Albert G. White III Vice President, Chief Strategy Officer
Age: 44
Bio & Compensation  - Reuters
Randal L. Golden Esq. General Counsel
Age: 52
Bio & Compensation  - Reuters